Out come of BM and Results unaudited 31 Dec 2025
Awaiting price reaction for this filing.
Lords Mark Industries Ltd's board, at its meeting on 14 February 2026, approved the unaudited standalone and consolidated financial results for Q3 FY26 and the nine months ended 31 December 2025. On a standalone basis, the company posted income from operations of Rs 15,024.36 lakh in Q3 (up sharply from Rs 948.12 lakh in Q2 FY26), with a net profit of Rs 1,395.29 lakh for the quarter and Rs 1,153.28 lakh for the nine months (basic EPS of Rs 0.41 and Rs 0.34 respectively). On a consolidated basis, including 5 subsidiaries (Lords Automative, Lords Green Energy, Lords Mark Biotech, Lords Mark Micro Biotech, and Renalyx Health Systems), Q3 revenue was Rs 18,093 lakh with a net profit of Rs 1,287.31 lakh and 9M revenue of Rs 19,357.29 lakh with PAT of Rs 1,076.67 lakh. The statutory auditor Sanjeev S Gupta & Associates issued an unmodified (clean) limited review report with no qualifications.
Strong positive for shareholders — the company has swung from full-year FY25 losses (standalone loss of Rs 672.89 lakh) to a robust nine-month profit, signaling a major turnaround in business operations. The clean auditor report and absence of qualifications remove any near-term governance overhang.